2seventy bio, Inc. (TSVT)
(Delayed Data from NSDQ)
$5.05 USD
+0.18 (3.70%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $5.06 +0.01 (0.20%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for 2seventy bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -217.57 | -254.15 | -292.21 | -120.11 | -320.59 |
Depreciation/Amortization & Depletion | 22.34 | 11.53 | 16.35 | 13.19 | 12.59 |
Net Change from Assets/Liabilities | 2.60 | -35.87 | 13.33 | -15.47 | 35.14 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 25.77 | 41.36 | 55.50 | 54.60 | 64.91 |
Net Cash From Operating Activities | -166.86 | -237.13 | -207.03 | -67.79 | -207.96 |
Property & Equipment | -13.87 | -22.84 | -11.58 | -22.26 | -59.77 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 57.73 | 34.54 | 34.99 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -8.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 43.86 | 11.70 | 15.41 | -22.26 | -59.77 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 127.39 | 166.23 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 354.89 | 90.05 | 267.72 |
Net Cash from Financing Activities | 127.39 | 166.23 | 354.89 | 90.05 | 267.72 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 4.39 | -59.21 | 163.27 | 0.00 | 0.00 |
Cash at Beginning of Period | 72.29 | 163.27 | 0.00 | 0.00 | 0.00 |
Cash at End of Period | 76.68 | 104.06 | 163.27 | 0.00 | 0.00 |
Diluted Net EPS | -4.42 | -7.13 | -12.44 | NA | NA |
Fiscal Year End for 2seventy bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -27.79 | -52.67 | -217.57 | -160.75 | -89.11 |
Depreciation/Amortization & Depletion | 3.78 | 2.11 | 22.34 | 19.31 | 4.49 |
Net Change from Assets/Liabilities | -0.35 | 2.01 | 2.60 | 15.67 | -12.09 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -40.66 | 6.68 | 25.77 | 22.51 | 14.95 |
Net Cash From Operating Activities | -65.02 | -41.88 | -166.86 | -103.26 | -81.75 |
Property & Equipment | -0.50 | -0.44 | -13.87 | -12.79 | -10.05 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 57.77 | 22.27 | 57.73 | 8.76 | -10.03 |
Other Investing Activities | 43.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 100.27 | 21.83 | 43.86 | -4.03 | -20.08 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.36 | 0.39 | 127.39 | 127.14 | 127.21 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.36 | 0.39 | 127.39 | 127.14 | 127.21 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 35.61 | -19.66 | 4.39 | 19.85 | 25.38 |
Cash at Beginning of Period | 76.68 | 76.68 | 72.29 | 72.29 | 72.29 |
Cash at End of Period | 112.30 | 57.03 | 76.68 | 92.14 | 97.67 |
Diluted Net EPS | 0.45 | -1.01 | -1.11 | -1.40 | -0.83 |